Mit Magzter GOLD unbegrenztes Potenzial nutzen

Mit Magzter GOLD unbegrenztes Potenzial nutzen

Erhalten Sie unbegrenzten Zugriff auf über 9.000 Zeitschriften, Zeitungen und Premium-Artikel für nur

$149.99
 
$74.99/Jahr

Versuchen GOLD - Frei

Does US cancer drug nod make Cipla attractive?

Mint Bangalore

|

April 18, 2025

Cipla, which makes HIV, respiratory and cancer drugs, is targeting North America with generic launches

- Dipti Sharma

Cipla Ltd's shares have surged 6% since last week when it announced the final approval from the US Food and Drug Administration for its generic version of Bristol Myers Squibb's Abraxane, a cancer drug. Does the approval to sell the much-awaited product in the US make Cipla a compelling buy, especially when Trump's tariffs loom?

"One product approval by itself doesn't suddenly make a company more attractive," said Prashant Nair, lead analyst for pharma and healthcare at Ambit Capital. "Earlier-than-expected approval for Abraxane is positive, but tariffs will have a bearing on Cipla."

WEITERE GESCHICHTEN VON Mint Bangalore

Mint Bangalore

Vedanta’s bond plan faces query on $600 mn loan funds

$250 mn of $500mn loan still not drawn: Vedanta

time to read

1 mins

September 30, 2025

Mint Bangalore

WeWork India preps ₹3,000 cr IPO in share sale by promoters

WeWork India Management Ltd, the country’s largest flexible workspace operator, will launch its initial public offering (IPO) on Friday as its shareholders plan to raise up t0 ₹3,000 crore.

time to read

1 mins

September 30, 2025

Mint Bangalore

Top exec’s exit puts focus on TCS Al woes

itself was overhauled at least three times in the past three years. The Mumbai-based firm isalso laying off 12,200 mid-to senior-level executives, or 2% of its workforce, to become “future ready”.

time to read

2 mins

September 30, 2025

Mint Bangalore

Dubai halts HDFC from adding new customers

HDFC Bank Ltd, the largest private sector lender, has been banned from onboarding new customers at its Dubai branch after a regulator flagged lapses in its processes. The bank was penalized by a Dubai regulator for offering financial services to local clients who were not onboarded at the Dubai International Financial Centre, the Mumbai-based lender said in an exchange filing late on Friday.

time to read

1 min

September 30, 2025

Mint Bangalore

Enviable dilemma

It's a dilemma that the Reserve Bank of India (RBI) wouldn't mind being caught in.

time to read

1 min

September 30, 2025

Mint Bangalore

Walmart CEO issues wake-up call: ‘AI Is going to change literally every job’

Walmart executives aren’tsugarcoating the message: Artificial intelligence will wipe out some jobs and reshape its workforce.

time to read

4 mins

September 30, 2025

Mint Bangalore

Personal shoppers lift India’s premium fashion retail sales

Stylists help customers mix and match outfits, boosting confidence and setting brands apart

time to read

2 mins

September 30, 2025

Mint Bangalore

Mint Bangalore

Russia's exports to India falter, UAE rises as formidable competitor

India’s imports from Russia declined 5.54% to $26.46 billion in the first five months of the current financial year, bringing the country’s secondlargest supplier of goods close to being overtaken by third-placed United Arab Emirates (UAE), government data showed.

time to read

1 mins

September 30, 2025

Mint Bangalore

Mint Bangalore

RACING AHEAD: ARE AUTO STOCKS STILL A BUY?

India's auto sector is displaying all the signs of a classic bull market. But there are risks

time to read

8 mins

September 30, 2025

Mint Bangalore

Govt warns Kerala on amoeba case surge

The central government has asked Kerala authorities to step up monitoring after the state reported a surge in cases of a rare brain-eating amoeba. Kerala health minister Veena George has said the state has recorded 80 cases and 21 deaths so far in 2025.

time to read

1 min

September 30, 2025

Listen

Translate

Share

-
+

Change font size